APO Research
Talk to an analyst

APO RESEARCH · REPORT

Exosome Isolation Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Exosome Isolation Service Market Outlook and Growth Opportunities 2026

30 January 2026210 pages

Choose your research edition.

Industry ResearchExosome Isolation Service Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Exosome Isolation Service Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Exosome Isolation Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Exosome Isolation Service Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Exosome Isolation Service Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Exosome Isolation Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Exosome Isolation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Exosome Isolation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Exosome Isolation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Exosome Isolation Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Exosome Isolation Service market include Codiak Biosciences, Aethlon Medical, NanoSomix, Aruna Bio, Creative Biostructure, AMSBIO, Everzom, System Biosciences and Creative Biolabs, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Exosome Isolation Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Exosome Isolation Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Exosome Isolation Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Exosome Isolation Service market.

Exosome Isolation Service Segment by Company

Codiak Biosciences

Aethlon Medical

NanoSomix

Aruna Bio

Creative Biostructure

AMSBIO

Everzom

System Biosciences

Creative Biolabs

Frontage Labs

Lonza

Capital Biosciences

Miltenyi Biotec

Novus Biologicals

Clara Biotech

Immunostep

ExosomeDx

Irvine Scientific

Beckman Coulter

Stratech

QIAGEN

Lifeasible

Exosome Isolation Service Segment by Type

Ultracentrifugation

Immunomagnetic Bead Method

Size Exclusion Chromatography

Exosome Isolation Service Segment by Application

Early Cancer Screening

Neurological Disease Diagnosis

Drug Delivery System Development

Regenerative Medicine

Other

Exosome Isolation Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Exosome Isolation Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Exosome Isolation Service key companies, revenue, market share, and recent developments.

3. To split the Exosome Isolation Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Exosome Isolation Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Exosome Isolation Service significant trends, drivers, influence factors in global and regions.

6. To analyze Exosome Isolation Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exosome Isolation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Exosome Isolation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exosome Isolation Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Exosome Isolation Service industry.

Chapter 3: Detailed analysis of Exosome Isolation Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Exosome Isolation Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Exosome Isolation Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Exosome Isolation Service Industry Trends Table 2. Exosome Isolation Service Industry Drivers Table 3. Exosome Isolation Service Industry Opportunities and Challenges Table 4. Exosome Isolation Service Industry Restraints Table 5. Global Exosome Isolation Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Exosome Isolation Service Revenue Share by Company (2021-2026) Table 7. Global Exosome Isolation Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Exosome Isolation Service Key Company Manufacturing Base & Headquarters Table 9. Global Exosome Isolation Service Company, Product Type & Application Table 10. Global Exosome Isolation Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Exosome Isolation Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Ultracentrifugation Table 15. Significant Companies of Immunomagnetic Bead Method Table 16. Significant Companies of Size Exclusion Chromatography Table 17. Global Exosome Isolation Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Exosome Isolation Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Exosome Isolation Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Exosome Isolation Service Sales Value Share by Type (2021-2026) Table 21. Global Exosome Isolation Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Early Cancer Screening Table 23. Significant Companies of Neurological Disease Diagnosis Table 24. Significant Companies of Drug Delivery System Development Table 25. Significant Companies of Regenerative Medicine Table 26. Significant Companies of Other Table 27. Global Exosome Isolation Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Exosome Isolation Service Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Exosome Isolation Service Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Exosome Isolation Service Sales Value Share by Application (2021-2026) Table 31. Global Exosome Isolation Service Sales Value Share by Application (2027-2032) Table 32. Global Exosome Isolation Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Exosome Isolation Service Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Exosome Isolation Service Sales Value Share by Region (2021-2026) Table 35. Global Exosome Isolation Service Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Exosome Isolation Service Sales Value Share by Region (2027-2032) Table 37. Global Exosome Isolation Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Exosome Isolation Service Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Exosome Isolation Service Sales Value Market Share by Country (2021-2026) Table 40. Global Exosome Isolation Service Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Exosome Isolation Service Sales Value Market Share by Country (2027-2032) Table 42. Codiak Biosciences Company Information Table 43. Codiak Biosciences Business Overview Table 44. Codiak Biosciences Exosome Isolation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Codiak Biosciences Exosome Isolation Service Product Portfolio Table 46. Codiak Biosciences Recent Development Table 47. Aethlon Medical Company Information Table 48. Aethlon Medical Business Overview Table 49. Aethlon Medical Exosome Isolation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Aethlon Medical Exosome Isolation Service Product Portfolio Table 51. Aethlon Medical Recent Development Table 52. NanoSomix Company Information Table 53. NanoSomix Business Overview Table 54. NanoSomix Exosome Isolation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. NanoSomix Exosome Isolation Service Product Portfolio Table 56. NanoSomix Recent Development Table 57. Aruna Bio Company Information Table 58. Aruna Bio Business Overview Table 59. Aruna Bio Exosome Isolation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Aruna Bio Exosome Isolation Service Product Portfolio Table 61. Aruna Bio Recent Development Table 62. Creative Biostructure Company Information Table 63. Creative Biostructure Business Overview Table 64. Creative Biostructure Exosome Isolation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Creative Biostructure Exosome Isolation Service Product Portfolio Table 66. Creative Biostructure Recent Development Table 67. AMSBIO Company Information Table 68. AMSBIO Business Overview Table 69. AMSBIO Exosome Isolation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. AMSBIO Exosome Isolation Service Product Portfolio Table 71. AMSBIO Recent Development Table 72. Everzom Company Information Table 73. Everzom Business Overview Table 74. Everzom Exosome Isolation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Everzom Exosome Isolation Service Product Portfolio Table 76. Everzom Recent Development Table 77. System Biosciences Company Information Table 78. System Biosciences Business Overview Table 79. System Biosciences Exosome Isolation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. System Biosciences Exosome Isolation Service Product Portfolio Table 81. System Biosciences Recent Development Table 82. Creative Biolabs Company Information Table 83. Creative Biolabs Business Overview Table 84. Creative Biolabs Exosome Isolation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Creative Biolabs Exosome Isolation Service Product Portfolio Table 86. Creative Biolabs Recent Development Table 87. Frontage Labs Company Information Table 88. Frontage Labs Business Overview Table 89. Frontage Labs Exosome Isolation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Frontage Labs Exosome Isolation Service Product Portfolio Table 91. Frontage Labs Recent Development Table 92. Lonza Company Information Table 93. Lonza Business Overview Table 94. Lonza Exosome Isolation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Lonza Exosome Isolation Service Product Portfolio Table 96. Lonza Recent Development Table 97. Capital Biosciences Company Information Table 98. Capital Biosciences Business Overview Table 99. Capital Biosciences Exosome Isolation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Capital Biosciences Exosome Isolation Service Product Portfolio Table 101. Capital Biosciences Recent Development Table 102. Miltenyi Biotec Company Information Table 103. Miltenyi Biotec Business Overview Table 104. Miltenyi Biotec Exosome Isolation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Miltenyi Biotec Exosome Isolation Service Product Portfolio Table 106. Miltenyi Biotec Recent Development Table 107. Novus Biologicals Company Information Table 108. Novus Biologicals Business Overview Table 109. Novus Biologicals Exosome Isolation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Novus Biologicals Exosome Isolation Service Product Portfolio Table 111. Novus Biologicals Recent Development Table 112. Clara Biotech Company Information Table 113. Clara Biotech Business Overview Table 114. Clara Biotech Exosome Isolation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Clara Biotech Exosome Isolation Service Product Portfolio Table 116. Clara Biotech Recent Development Table 117. Immunostep Company Information Table 118. Immunostep Business Overview Table 119. Immunostep Exosome Isolation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Immunostep Exosome Isolation Service Product Portfolio Table 121. Immunostep Recent Development Table 122. ExosomeDx Company Information Table 123. ExosomeDx Business Overview Table 124. ExosomeDx Exosome Isolation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. ExosomeDx Exosome Isolation Service Product Portfolio Table 126. ExosomeDx Recent Development Table 127. Irvine Scientific Company Information Table 128. Irvine Scientific Business Overview Table 129. Irvine Scientific Exosome Isolation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Irvine Scientific Exosome Isolation Service Product Portfolio Table 131. Irvine Scientific Recent Development Table 132. Beckman Coulter Company Information Table 133. Beckman Coulter Business Overview Table 134. Beckman Coulter Exosome Isolation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Beckman Coulter Exosome Isolation Service Product Portfolio Table 136. Beckman Coulter Recent Development Table 137. Stratech Company Information Table 138. Stratech Business Overview Table 139. Stratech Exosome Isolation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Stratech Exosome Isolation Service Product Portfolio Table 141. Stratech Recent Development Table 142. QIAGEN Company Information Table 143. QIAGEN Business Overview Table 144. QIAGEN Exosome Isolation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. QIAGEN Exosome Isolation Service Product Portfolio Table 146. QIAGEN Recent Development Table 147. Lifeasible Company Information Table 148. Lifeasible Business Overview Table 149. Lifeasible Exosome Isolation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Lifeasible Exosome Isolation Service Product Portfolio Table 151. Lifeasible Recent Development Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Exosome Isolation Service Product Image Figure 2. Global Exosome Isolation Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Exosome Isolation Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Exosome Isolation Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Ultracentrifugation Image Figure 8. Immunomagnetic Bead Method Image Figure 9. Size Exclusion Chromatography Image Figure 10. Global Exosome Isolation Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Exosome Isolation Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Exosome Isolation Service Sales Value Share by Type (2021-2032) Figure 13. Early Cancer Screening Image Figure 14. Neurological Disease Diagnosis Image Figure 15. Drug Delivery System Development Image Figure 16. Regenerative Medicine Image Figure 17. Other Image Figure 18. Global Exosome Isolation Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Exosome Isolation Service Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Exosome Isolation Service Sales Value Share by Application (2021-2032) Figure 21. Global Exosome Isolation Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Exosome Isolation Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Exosome Isolation Service Sales Value (2021-2032) & (US$ Million) Figure 24. North America Exosome Isolation Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Exosome Isolation Service Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Exosome Isolation Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Exosome Isolation Service Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Exosome Isolation Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Exosome Isolation Service Sales Value (2021-2032) & (US$ Million) Figure 30. South America Exosome Isolation Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Exosome Isolation Service Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Exosome Isolation Service Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Exosome Isolation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Ultracentrifugation
  • Immunomagnetic Bead Method
  • Size Exclusion Chromatography
Applications
  • Early Cancer Screening
  • Neurological Disease Diagnosis
  • Drug Delivery System Development
  • Regenerative Medicine
  • Other
Companies covered
  • Codiak Biosciences
  • Aethlon Medical
  • NanoSomix
  • Aruna Bio
  • Creative Biostructure
  • AMSBIO
  • Everzom
  • System Biosciences
  • Creative Biolabs
  • Frontage Labs
  • Lonza
  • Capital Biosciences
  • Miltenyi Biotec
  • Novus Biologicals
  • Clara Biotech
  • Immunostep
  • ExosomeDx
  • Irvine Scientific
  • Beckman Coulter
  • Stratech
  • QIAGEN
  • Lifeasible

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Exosome Isolation Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Exosome Isolation Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Exosome Isolation Service Market Dynamics
  1. 2.1 Exosome Isolation Service Industry Trends
  2. 2.2 Exosome Isolation Service Industry Drivers
  3. 2.3 Exosome Isolation Service Industry Opportunities and Challenges
  4. 2.4 Exosome Isolation Service Industry Restraints
3 Exosome Isolation Service Market by Company
  1. 3.1 Global Exosome Isolation Service Company Revenue Ranking in 2025
  2. 3.2 Global Exosome Isolation Service Revenue by Company (2021-2026)
  3. 3.3 Global Exosome Isolation Service Company Ranking (2024-2026)
  4. 3.4 Global Exosome Isolation Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Exosome Isolation Service Company Product Type and Application
  6. 3.6 Global Exosome Isolation Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Exosome Isolation Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Exosome Isolation Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Exosome Isolation Service Market by Type
  1. 4.1 Exosome Isolation Service Type Introduction
  2. 4.1.1 Ultracentrifugation
  3. 4.1.2 Immunomagnetic Bead Method
  4. 4.1.3 Size Exclusion Chromatography
  5. 4.2 Global Exosome Isolation Service Sales Value by Type
  6. 4.2.1 Global Exosome Isolation Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Exosome Isolation Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global Exosome Isolation Service Sales Value Share by Type (2021-2032)
5 Exosome Isolation Service Market by Application
  1. 5.1 Exosome Isolation Service Application Introduction
  2. 5.1.1 Early Cancer Screening
  3. 5.1.2 Neurological Disease Diagnosis
  4. 5.1.3 Drug Delivery System Development
  5. 5.1.4 Regenerative Medicine
  6. 5.1.5 Other
  7. 5.2 Global Exosome Isolation Service Sales Value by Application
  8. 5.2.1 Global Exosome Isolation Service Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Exosome Isolation Service Sales Value by Application (2021-2032)
  10. 5.2.3 Global Exosome Isolation Service Sales Value Share by Application (2021-2032)
6 Exosome Isolation Service Regional Value Analysis
  1. 6.1 Global Exosome Isolation Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Exosome Isolation Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Exosome Isolation Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Exosome Isolation Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Exosome Isolation Service Sales Value (2021-2032)
  7. 6.3.2 North America Exosome Isolation Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Exosome Isolation Service Sales Value (2021-2032)
  10. 6.4.2 Europe Exosome Isolation Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Exosome Isolation Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Exosome Isolation Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Exosome Isolation Service Sales Value (2021-2032)
  16. 6.6.2 South America Exosome Isolation Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Exosome Isolation Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Exosome Isolation Service Sales Value Share by Country, 2025 VS 2032
7 Exosome Isolation Service Country-level Value Analysis
  1. 7.1 Global Exosome Isolation Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Exosome Isolation Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Exosome Isolation Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Exosome Isolation Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Exosome Isolation Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Exosome Isolation Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Exosome Isolation Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Codiak Biosciences
  2. 8.1.1 Codiak Biosciences Company Information
  3. 8.1.2 Codiak Biosciences Business Overview
  4. 8.1.3 Codiak Biosciences Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Codiak Biosciences Exosome Isolation Service Product Portfolio
  6. 8.1.5 Codiak Biosciences Recent Developments
  7. 8.2 Aethlon Medical
  8. 8.2.1 Aethlon Medical Company Information
  9. 8.2.2 Aethlon Medical Business Overview
  10. 8.2.3 Aethlon Medical Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Aethlon Medical Exosome Isolation Service Product Portfolio
  12. 8.2.5 Aethlon Medical Recent Developments
  13. 8.3 NanoSomix
  14. 8.3.1 NanoSomix Company Information
  15. 8.3.2 NanoSomix Business Overview
  16. 8.3.3 NanoSomix Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 NanoSomix Exosome Isolation Service Product Portfolio
  18. 8.3.5 NanoSomix Recent Developments
  19. 8.4 Aruna Bio
  20. 8.4.1 Aruna Bio Company Information
  21. 8.4.2 Aruna Bio Business Overview
  22. 8.4.3 Aruna Bio Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Aruna Bio Exosome Isolation Service Product Portfolio
  24. 8.4.5 Aruna Bio Recent Developments
  25. 8.5 Creative Biostructure
  26. 8.5.1 Creative Biostructure Company Information
  27. 8.5.2 Creative Biostructure Business Overview
  28. 8.5.3 Creative Biostructure Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Creative Biostructure Exosome Isolation Service Product Portfolio
  30. 8.5.5 Creative Biostructure Recent Developments
  31. 8.6 AMSBIO
  32. 8.6.1 AMSBIO Company Information
  33. 8.6.2 AMSBIO Business Overview
  34. 8.6.3 AMSBIO Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AMSBIO Exosome Isolation Service Product Portfolio
  36. 8.6.5 AMSBIO Recent Developments
  37. 8.7 Everzom
  38. 8.7.1 Everzom Company Information
  39. 8.7.2 Everzom Business Overview
  40. 8.7.3 Everzom Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Everzom Exosome Isolation Service Product Portfolio
  42. 8.7.5 Everzom Recent Developments
  43. 8.8 System Biosciences
  44. 8.8.1 System Biosciences Company Information
  45. 8.8.2 System Biosciences Business Overview
  46. 8.8.3 System Biosciences Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 System Biosciences Exosome Isolation Service Product Portfolio
  48. 8.8.5 System Biosciences Recent Developments
  49. 8.9 Creative Biolabs
  50. 8.9.1 Creative Biolabs Company Information
  51. 8.9.2 Creative Biolabs Business Overview
  52. 8.9.3 Creative Biolabs Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Creative Biolabs Exosome Isolation Service Product Portfolio
  54. 8.9.5 Creative Biolabs Recent Developments
  55. 8.10 Frontage Labs
  56. 8.10.1 Frontage Labs Company Information
  57. 8.10.2 Frontage Labs Business Overview
  58. 8.10.3 Frontage Labs Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Frontage Labs Exosome Isolation Service Product Portfolio
  60. 8.10.5 Frontage Labs Recent Developments
  61. 8.11 Lonza
  62. 8.11.1 Lonza Company Information
  63. 8.11.2 Lonza Business Overview
  64. 8.11.3 Lonza Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Lonza Exosome Isolation Service Product Portfolio
  66. 8.11.5 Lonza Recent Developments
  67. 8.12 Capital Biosciences
  68. 8.12.1 Capital Biosciences Company Information
  69. 8.12.2 Capital Biosciences Business Overview
  70. 8.12.3 Capital Biosciences Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Capital Biosciences Exosome Isolation Service Product Portfolio
  72. 8.12.5 Capital Biosciences Recent Developments
  73. 8.13 Miltenyi Biotec
  74. 8.13.1 Miltenyi Biotec Company Information
  75. 8.13.2 Miltenyi Biotec Business Overview
  76. 8.13.3 Miltenyi Biotec Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Miltenyi Biotec Exosome Isolation Service Product Portfolio
  78. 8.13.5 Miltenyi Biotec Recent Developments
  79. 8.14 Novus Biologicals
  80. 8.14.1 Novus Biologicals Company Information
  81. 8.14.2 Novus Biologicals Business Overview
  82. 8.14.3 Novus Biologicals Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Novus Biologicals Exosome Isolation Service Product Portfolio
  84. 8.14.5 Novus Biologicals Recent Developments
  85. 8.15 Clara Biotech
  86. 8.15.1 Clara Biotech Company Information
  87. 8.15.2 Clara Biotech Business Overview
  88. 8.15.3 Clara Biotech Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Clara Biotech Exosome Isolation Service Product Portfolio
  90. 8.15.5 Clara Biotech Recent Developments
  91. 8.16 Immunostep
  92. 8.16.1 Immunostep Company Information
  93. 8.16.2 Immunostep Business Overview
  94. 8.16.3 Immunostep Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Immunostep Exosome Isolation Service Product Portfolio
  96. 8.16.5 Immunostep Recent Developments
  97. 8.17 ExosomeDx
  98. 8.17.1 ExosomeDx Company Information
  99. 8.17.2 ExosomeDx Business Overview
  100. 8.17.3 ExosomeDx Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 ExosomeDx Exosome Isolation Service Product Portfolio
  102. 8.17.5 ExosomeDx Recent Developments
  103. 8.18 Irvine Scientific
  104. 8.18.1 Irvine Scientific Company Information
  105. 8.18.2 Irvine Scientific Business Overview
  106. 8.18.3 Irvine Scientific Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Irvine Scientific Exosome Isolation Service Product Portfolio
  108. 8.18.5 Irvine Scientific Recent Developments
  109. 8.19 Beckman Coulter
  110. 8.19.1 Beckman Coulter Company Information
  111. 8.19.2 Beckman Coulter Business Overview
  112. 8.19.3 Beckman Coulter Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Beckman Coulter Exosome Isolation Service Product Portfolio
  114. 8.19.5 Beckman Coulter Recent Developments
  115. 8.20 Stratech
  116. 8.20.1 Stratech Company Information
  117. 8.20.2 Stratech Business Overview
  118. 8.20.3 Stratech Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Stratech Exosome Isolation Service Product Portfolio
  120. 8.20.5 Stratech Recent Developments
  121. 8.21 QIAGEN
  122. 8.21.1 QIAGEN Company Information
  123. 8.21.2 QIAGEN Business Overview
  124. 8.21.3 QIAGEN Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  125. 8.21.4 QIAGEN Exosome Isolation Service Product Portfolio
  126. 8.21.5 QIAGEN Recent Developments
  127. 8.22 Lifeasible
  128. 8.22.1 Lifeasible Company Information
  129. 8.22.2 Lifeasible Business Overview
  130. 8.22.3 Lifeasible Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Lifeasible Exosome Isolation Service Product Portfolio
  132. 8.22.5 Lifeasible Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst